Barbara Savoldo, MD, Ph.D., UNC Lineberger Comprehensive Cancer Center (IMAGE)

UNC Lineberger Comprehensive Cancer Center

Barbara Savoldo, MD, Ph.D., UNC Lineberger Comprehensive Cancer Center

Caption

Barbara Savaldo, MD, Ph.D., and colleagues at UNC Lineberger Comprehensive Cancer Center and Baylor College of Medicine report that results from an early-phase clinical trial demonstrated CAR-T cell therapy was highly active in patients with relapsed/refractory Hodgkin lymphoma. The treatment led to the complete disappearance of tumor in the majority of patients treated at the highest dose level of therapy with almost all patients having clinical benefit after treatment.

Credit

UNC Lineberger Comprehensive Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.